LXRX
NASDAQ · Pharmaceuticals
Lexicon Pharmaceuticals Inc
$1.63
+0.02 (+1.24%)
Open$1.59
Previous Close$1.61
Day High$1.66
Day Low$1.58
52W High$1.95
52W Low$0.51
Volume—
Avg Volume1.89M
Market Cap726.61M
P/E Ratio—
EPS$-0.14
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+1,002.5% upside
Current
$1.63
$1.63
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 61.16M | 68.34M | 62.90M |
| Net Income | -61,828,906 | 19.40M | 18.23M |
| Profit Margin | -101.1% | 28.4% | 29.0% |
| EBITDA | -50,818,279 | 29.54M | 28.34M |
| Free Cash Flow | — | 10.65M | 12.86M |
| Rev Growth | +692.7% | +10.7% | +9.3% |
| Debt/Equity | 0.50 | 0.92 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |